A Pilot Study to Explore the Role of Gut Flora in Lupus
NCT04213690 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2025-06-05
Summary
This study seeks to correlate microbiome sequencing data with information provided by patients and their medical records.
Conditions
- Lupus Erythematosus
- Lupus Erythematosus, Systemic
Interventions
- OTHER
-
No Intervention
There is no intervention for this study
Sponsors & Collaborators
-
ProgenaBiome
lead OTHER
Principal Investigators
-
Sabine Hazan, MD · ProgenaBiome
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-03-02
- Primary Completion
- 2030-03-31
- Completion
- 2030-07-31
Countries
- United States
Study Locations
More Related Trials
-
Study of Systemic Lupus Erythematosus
NCT00001372 ·Status: RECRUITING
-
Open Label Pilot Trial of Rituximab in Lupus Membranous Nephritis
NCT00908986 ·Status: WITHDRAWN ·Phase: NA
-
A Study of Skin and Systemic Biomarkers In Patients With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers
NCT02034344 ·Status: COMPLETED
-
Serologically Active, Clinically Stable Systemic Lupus Erythematosus
NCT00000421 ·Status: COMPLETED ·Phase: PHASE2
-
Immune Ablation and Hematopoietic Stem Cell Support in Patients With Systemic Lupus Erythematosus: A Phase II Study
NCT00271934 ·Status: COMPLETED ·Phase: PHASE2
-
Biomarkers of Lupus Disease: Serial Biomarker Sampling in Patients With Active Systemic Lupus Erythematosus (SLE)
NCT00987831 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Translation of a Diagnostic Test for Lupus Flare Prediction From Bench to Clinic
NCT04018222 ·Status: UNKNOWN
-
A Research Study to Assess if CC-930 is Safe in Treating Subjects With Discoid Lupus Erythematosus
NCT01466725 ·Status: TERMINATED ·Phase: PHASE2
-
Exploring Biomarkers for Therapeutic Response of Lupus Nephritis Based on Multi Omics Analysis
NCT06167174 ·Status: RECRUITING
-
Gynecological Symptoms and Health-related Quality of Life in Egyptian Women With SLE
NCT05230316 ·Status: UNKNOWN
-
Examining Distinct Immunophenotypes to Validate and Enhance Rational Treatment in Systemic Lupus
NCT05306873 ·Status: TERMINATED ·Phase: PHASE2
-
A Study on Protein Losing Enteropathy In Systemic Lupus Erythematosus
NCT04517240 ·Status: UNKNOWN
-
Mediterranean vs. High-Fermented-Food Diet Adherence on Inflammation in Lupus
NCT05379725 ·Status: TERMINATED ·Phase: NA
-
A Safety and Tolerability Study of MEDI-570 in Systemic Lupus Erythematosus
NCT01127321 ·Status: TERMINATED ·Phase: PHASE1
-
Accuracy, Feasibility and Acceptance of CGM Lupus
NCT03296995 ·Status: UNKNOWN ·Phase: NA
-
Induction Treatment of Proliferative Lupus Nephritis With Leflunomide Combined With Prednisone
NCT00268567 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Assessment of Cognitive Function and Gut Microbiota Analysis in Real World Patients With Lupus Cerebrovascular Disease
NCT05636670 ·Status: UNKNOWN
-
Effect of Curcumin on Systemic Lupus Erythematosus
NCT03953261 ·Status: TERMINATED ·Phase: PHASE2
-
Safety of Estrogens in Lupus: Birth Control Pills
NCT00000420 ·Status: COMPLETED ·Phase: PHASE3
-
Study of CM313(SC) Injection in Systemic Lupus Erythematosus(SLE)
NCT06791772 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
A IMMA Master Protocol: A Study of LY3361237 in Participants With at Least Moderately Active Systemic Lupus Erythematosus
NCT05123586 ·Status: TERMINATED ·Phase: PHASE2
-
Acceptability and Persistence of the Use of a Patient-centred E-health Tool for Lupus Patients Followed in a Specialised Centre in France
NCT03953690 ·Status: TERMINATED
-
Epidemiologic Study of Reproductive Outcome in Women With Systemic Lupus Erythematosus
NCT00004663 ·Status: COMPLETED
-
A Study Evaluating the Effects of GLPG3667 Administered as Oral Treatment in Adult Participants With Active Systemic Lupus Erythematosus
NCT05856448 ·Status: COMPLETED ·Phase: PHASE2
-
Systemic Lupus and Adverse Pregnancy Outcome
NCT03171103 ·Status: UNKNOWN